ASX Announcements

EXCERPT:  January 15, 2019 – Invitrocue Limited (ASX: IVQ), a leading healthcare bio-analytic solutions provider, is pleased to announce the appointment of Professor Jesús García-Foncillas as Clinical Advisor of Invitrocue. Professor Jesús is an experienced oncology researcher with 25 years of experience in cancer diagnosis and treatment. He holds multiple executive leadership positions at “Fundacion …

Read more

[:en]EXCERPT: January 11, 2019 – Invitrocue Limited (ASX: IVQ), a leader healthcare bio-analytic solutions provider, is pleased to announce the appointment of Professor Masakazu Toi as Clinical Advisor of Invitrocue. A renowned oncology expert having held various roles as healthcare provider, scholar, and opinion leader, Professor Toi brings strong clinical oncology knowledge and experience especially …

Read more

[:en]EXCERPT: January 9, 2019 – Invitrocue Limited (ASX : IVQ), a leading healthcare bio-analytic solutions provider, announces the appointment of Dr. Steven Fang as Chairman of the Company’s Board of Directors with immediate effect. Dr. Fang is a co-founder and the Executive Director of Invitrocue with more than 20 years’ experience in leading and building successful …

Read more